Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-01

Clinical Trial Update: Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)

View source ↗

Summary

A completed clinical trial evaluating MK-0954A for managing hypertension by reducing uric acid; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MK-0954A

Snippet

Sponsor: Organon and Co | Conditions: Hypertension | Status: COMPLETED | Results posted: 2011-09-01